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CORRESPONDENCE
Chronic Candida Arthritis in Leukemic Patients
SIR - We read with interest the report of Fainstein
et al. [1] as well as their review on candida arthritis
in patients with cancer. Since the data on the
pathology of candidal arthritis in humans are very
limited, we would like to draw attention to a case
not included in their review; it involved a patient
with acute myeloblastic leukemia [2]. Because of
misdiagnosis despite positive joint cultures, this
patient had a chronic arthritis of the knee due to
C. albicans that evolved over a nine-month period
during which there was no specific treatment. A
synovial biopsy was performed four months after
appearance of the first symptoms and revealed
nonspecific histologic signs of inflammation and
no visible fungi. Radiographs of the joint per-
formed eight months after onset revealed patchy
areas of rarefaction in the femoral epiphysis.
There was transient improvement when am-
photericin B was started eight months after onset,
but the patient soon died of his underlying disease.
At autopsy there was evidence of disseminated vis-
ceral fungal infection presenting as pseudotu-
moral nodules. The affected knee joint showed
localized cartilaginous erosions; microscopic ex-
amination showed that these were riddled with
numerous fungal filaments. The adjacent bone
Erratum
showed atrophy but no foci of infection. This case
of a chronic C. albicans arthritis in a leukemic pa-
tient shows that radiologic abnormalities as well as
cartilaginous lesions may develop with time. This
observation is in contrast to the lack of cartilage
and bone involvement observed by Fainstein et al.
in their patients with acute C. albicans arthritis. In
the latter group the lesions remained surprisingly
limited despite the incompetence of the patients'
host defenses.
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In "Some Observations on the Pneumococcus and on the Current Status of
Pneumococcal Disease and Its Prevention" by Robert Austrian (March-April
1981 Supplement), an error was made on page S2. The compound designated
2-acetamido-2- ,4-,6-trideoxygalactose
should read
2-acetamido-4-amino-2,4,6-trideoxygalactose.
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